Loading...
Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus‐infected patients with renal impairment: results from a 7‐year, multicentre retrospective cohort study
BACKGROUND: Limited data exist regarding tenofovir disoproxil fumarate (TDF) safety and effectiveness in chronic hepatitis B virus–infected (CHB) patients with renal impairment (RI). AIMS: To compare real‐world data on renal safety and effectiveness of TDF vs entecavir (ETV) in CHB patients with mod...
Na minha lista:
| Udgivet i: | Aliment Pharmacol Ther |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7383725/ https://ncbi.nlm.nih.gov/pubmed/32583915 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.15901 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|